Nominations of candidates for the Scheele Award 2021 before September 15th
It’s time to nominate your candidate for the 2021 Scheele Award – marking the 50th time for one of Sweden’s most prestigious prize in the field of pharmaceutical research to be awarded.
The Swedish Pharmaceutical Society biannually bestows the Scheele Award on a prominent scientist in the field of drug research or related disciplines. The award was named after Carl Wilhelm Scheele, the world-renowned Swedish 18th century chemist and pharmacist.
In addition to the excellent lectures traditionally held at the Scheele Symposium, the celebration of the 50th award since the start in 1961 will be something out of the ordinary.
So, who would be the worthiest recipient of the 50th Scheele Award? Please submit the Nomination form (find below) or send the corresponding information to Lisa Bandholtz, secretary of the Scheele Award Committee, no later than 15 September 2020. Ideally, up to three candidates can be put forward for consideration by the Nomination Committee. Obviously, we encourage nominations of both female and male candidates.
The Scheele Laureate will be appointed within the wide area of ongoing pharmaceutical research. The candidate should be an internationally recognized scientist, professionally active within the fields of drug research and drug development.
A special Scheele Symposium with a scientific program based on the Laureate’s area of research is to be organized in Stockholm in November 2021 in connection with the prize ceremony, where the Scheele Laureate will be awarded a prize sum of SEK 225 000 (appr. EUR 21 000).
The Swedish Pharmaceutical Society is a non-profit organization gathering professionals engaged in the field of medicinal drugs. Dating back to the 18th century, the society strives to be the professional voice of pharmaceutical science with the overarching aim to drive and support research and innovation in medicines and healthcare – and to promote high, professional standards throughout the value chain – from drug discovery to rational use.